Jaslok Hospital and Research Centre, Mumbai, India   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Mumbai India (1973)

Organization Overview

First Clinical Trial
2004
NCT02785653
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Consultant Oncologist, Jaslok Hospital and Research Centre, Mumbai, India | Jaslok Hospital and Reseach Centre, Mumbai | Jaslok Hospital, Mumbai | Jaslok Hospital, Mumbai, India | Jaslok Hospital & Research Centre | Medical Oncologist, Jaslok Hospital, Mumbai | Movement Disorder Clinic, Jaslok Hospital, Mumbai, India

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Gaucher Disease (Phase 2)

Glioblastoma (Phase 2)

Ischemia (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Parkinson Disease (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 10